WallStreetZenWallStreetZen

NASDAQ: NVAX
Novavax Inc Earnings & Revenue

NVAX past revenue growth

How has NVAX's revenue growth performed historically?
Company
-50.36%
Industry
165.61%
Market
17.84%
NVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NVAX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
NVAX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

NVAX earnings and revenue history

Current Revenue
$983.7M
Current Earnings
-$545.1M
Current Profit Margin
-55.4%

NVAX Return on Equity

Current Company
N/A
Current Industry
-63.6%
Current Market
188%

Be the first to know when NVAX announces earnings.

NVAX Return on Assets

Current Company
-32.6%
Current Industry
3%
NVAX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NVAX Return on Capital Employed

Current Company
-325.6%
Current Industry
19.6%
NVAX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NVAX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NVAX$983.71M-$487.39M-$545.06M+95.68%N/A
SLRN$0.00-$381.37M-$381.64MN/AN/A
CVAC$45.62M-$294.67M-$321.59M-24.38%N/A
CELC$0.00-$58.31M-$63.78MN/AN/A
NGNE$0.00-$32.35M-$36.32M-100.00%N/A

NVAX earnings dates

Next earnings date
May 7, 2024

Novavax Earnings & Revenue FAQ

What were NVAX's earnings last quarter?

On Invalid Date, Novavax (NASDAQ: NVAX) reported Q4 2023 earnings per share (EPS) of -$1.47, up 35.81% year over year. Total Novavax earnings for the quarter were -$178.39 million. In the same quarter last year, Novavax's earnings per share (EPS) was -$2.29.

If you're new to stock investing, here's how to buy Novavax stock.

What was NVAX's earnings growth in the past year?

As of Q1 2024, Novavax's earnings has grown year over year. Novavax's earnings in the past year totalled -$545.06 million.

What is NVAX's earnings date?

Novavax's earnings date is Invalid Date. Add NVAX to your watchlist to be reminded of NVAX's next earnings announcement.

What was NVAX's revenue last quarter?

On Invalid Date, Novavax (NASDAQ: NVAX) reported Q4 2023 revenue of $291.34 million up 18.48% year over year. In the same quarter last year, Novavax's revenue was $357.40 million.

What was NVAX's revenue growth in the past year?

As of Q1 2024, Novavax's revenue has grown -50.36% year over year. This is 215.98 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Novavax's revenue in the past year totalled $983.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.